Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavannah Resources Regulatory News (SAV)

Share Price Information for Savannah Resources (SAV)

Share Price is delayed by 15 minutes
Get Live Data
7.10    0.20 (2.90%)
Bid:
7.00
Ask:
7.20
Spread: 0.20 (2.857%)
Market Cap: £182.86m
SAV Live PriceLast checked at - London Stock Exchange

Intraday Savannah Resources Share Chart

Director/PDMR Shareholding

6 Jul 2022 16:45

RNS Number : 5824R
Savannah Resources PLC
06 July 2022
 

 

6 July 2022

 

Savannah Resources Plc

(AIM: SAV, FWB: SAV and SWB: SAV) ('Savannah,' 'Company,' 'Proponent')

 

PDMR Notification

Savannah, the resource development company focused on becoming Europe's most significant producer of spodumene lithium concentrate from its Barroso Lithium Project in Portugal, has been informed that, Mr Michael McGarty, CFO, aquired a total of 214,316 Ordinary Shares of £0.01 each in the Company ("Ordinary Shares") at an average price of 2.333 pence per Ordinary Share, totalling £4,999,99.

 

Following this acquisition Mr McGarty has a total beneficial interest in 1,222,054 Ordinary Shares, representing 0.07% of the Company's issued shared capital.

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM:

1. 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Christopher Michael McGarty

2.

Reason for the notification

a)

Position/status:

CFO

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor

a)

Name:

Savannah Resources Plc

b)

LEI:

213800UCK16HW5KKGP60

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)

Description of the financial instrument, type of instrument:

Identification code:

 

Ordinary Shares of £0.01 each

ISIN:GB00B647W791

b)

Nature of the transaction:

Purchase of Ordinary Shares

c)

Price(s) and volume(s):

 

Price(s)

Volume(s)

2.333 pence

 

214,316

 

d)

Aggregated information:

Aggregated volume:

Price:

 

Single transaction as in 4 c) above

e)

Date of the transaction:

6 July 2022

f)

Place of the transaction:

London Stock Exchange

 

Regulatory Information

This Announcement contains inside information for the purposes of the UK version of the market abuse regulation (EU No. 596/2014) as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 ("UK MAR").

 

Savannah - Enabling Europe's energy transition.

**ENDS**

Follow @SavannahRes on Twitter

Follow Savannah Resources on LinkedIn

 

For further information please visit www.savannahresources.com or contact:

 

Savannah Resources PLC

Dale Ferguson, CEO

 

 

Tel: +44 20 7117 2489

 

SP Angel Corporate Finance LLP (Nominated Advisor)

David Hignell / Charlie Bouverat

 

 

Tel: +44 20 3470 0470

 

 

finnCap Ltd (Joint Broker)

Christopher Raggett/ Tim Redfern

 

 

Tel: +44 20 7220 0500

 

RBC Capital Markets (Joint Broker)

Farid Dadashev/ Jamil Miah

 

Tel: +44 (0) 20 7653 4000

WH Ireland Limited (Joint Broker)

Jessica Cave/ Ben Good/ Darshan Patel (Corporate Finance)

Aimee McCusker (Corporate Broking)

 

Tel: +44 20 7220 1666

 

 

Camarco (Financial PR)

Gordon Poole/ Emily Hall

Tel: +44 20 3757 4980

 

 

About Savannah

Savannah is the owner of the Barroso Lithium Project, located close to key infrastructure in Northern Portugal which contains the most significant spodumene lithium resource in Western Europe. With a positive Scoping Study which outlined a conventional mine and concentrator operation producing 175,000t of spodumene concentrate per annum, Savannah is progressing the development and environmental licensing of the Barroso Lithium Project. A Definitive Feasibility Study is underway, and Portugal's environmental regulator is currently evaluating Savannah's Environmental Impact Assessment study. The Company is listed and regulated on the London Stock Exchange's Alternative Investment Market (AIM: SAV). The Company's ordinary shares are also available on the Quotation Board of the Frankfurt Stock Exchange (FWB: SAV), and the Börse Stuttgart (SWB: SAV).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFSEDLIRIIF
Date   Source Headline
10th Jul 20257:00 amRNSNew Corporate Presentation
2nd Jul 20257:00 amRNSRetail Offer increases Fundraise to £4.8 million
27th Jun 20257:20 amRNSResult of Accelerated Bookbuild and Subscription
26th Jun 20255:00 pmRNSRetailBook Offer
26th Jun 20254:51 pmRNSProposed Fundraise
18th Jun 20251:27 pmRNSPDMR Notification
16th Jun 20257:00 amRNSSavannah Announces Advisory Committee
12th Jun 20257:00 amRNSBarroso Lithium Project - Update
10th Jun 202512:04 pmRNSResult of AGM
10th Jun 20257:00 amRNSAGM Statement
29th May 20257:02 amRNSMore encouraging results in third batch of assays
16th May 202512:00 pmRNSNotice of Annual General Meeting
14th May 20257:00 amRNS-RResearch Initiation by Canaccord Genuity
8th May 20257:00 amRNS-RConference Participation during May & June 2025
1st May 20257:00 amRNSInvestor Presentation
30th Apr 20257:00 amRNSEncouraging results in second batch of assays
24th Apr 20252:44 pmRNS-RSavannah CEO interviewed on Crux Investor podcast
23rd Apr 20257:00 amRNSInvestor Presentation
22nd Apr 20258:47 amRNSHolding(s) in Company
14th Apr 20257:00 amRNSCFO, CCO and Commercialisation Appointments
10th Apr 20257:00 amRNSFinancial Results for Year Ended 31 December 2024
8th Apr 20257:00 amRNSMore progress made at the Barroso Lithium Project
4th Apr 202512:09 pmRNSHolding(s) in Company
27th Mar 20257:00 amRNSEncouraging first assays from Phase 2 drilling
25th Mar 20253:58 pmRNSBLP designated as Strategic Project under EU CRMA
24th Mar 20257:00 amRNSAppointment of Joint Corporate Broker
21st Feb 20257:00 amRNSRestart of fieldwork at Project
20th Feb 202512:09 pmRNSHolding(s) in Company
7th Feb 20258:01 amRNSClaim filed in relation to temporary land access
3rd Feb 20257:00 amRNS-RSavannah CEO interviewed on Dig Deep Podcast
27th Jan 20257:00 amRNSNew Corporate Presentation
22nd Jan 20257:06 amRNSNew Lithium Mineralisation Identified at Project
15th Jan 20252:56 pmRNSHolding(s) in Company
14th Jan 20257:00 amRNSInvestor Presentation
14th Jan 20257:00 amRNSProject update: Excellent progress being made
9th Jan 20257:00 amRNSSecond phase of DFS drilling underway
19th Dec 20247:00 amRNSChairman's Year End Statement
12th Dec 20247:00 amRNSRestart of Fieldwork & Aldeia Mining Lease Awarded
4th Dec 20243:01 pmRNSHolding(s) in Company
3rd Dec 20247:00 amRNSLoI for up to $270m loan guarantee from Germany
18th Nov 20243:47 pmRNSHolding(s) in Company
22nd Oct 20242:16 pmRNSHolding(s) in Company
16th Oct 20241:07 pmRNSHolding(s) in Company
14th Oct 20247:00 amRNS-RNew corporate presentation
3rd Oct 20247:00 amRNSInvestor Presentation
30th Sep 20247:00 amRNSInterim Results for Six Months Ended 30 June 2024
20th Aug 20247:00 amRNSAppointment of AMG Representative to Board
19th Aug 20243:23 pmRNSNotification of Major Shareholding
5th Aug 20241:32 pmRNSNotification of Major Shareholding
1st Aug 202411:18 amRNSPortuguese shareholding increases to c.12%

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.